Overexpression of the sarcolemmal calcium pump in the myocardium of transgenic rats

Item Type:	Article
Title:	Overexpression of the sarcolemmal calcium pump in the myocardium of transgenic rats
Creators Name:	Hammes, A. and Oberdorf-Maass, S. and Rother, T. and Nething, K. and Gollnick, F. and Linz, K.W. and Meyer, R. and Hu, K. and Han, H. and Gaudron, P. and Ertl, G. and Hoffmann, S. and Ganten, U. and Vetter, R. and Schuh, K. and Benkwitz, C. and Zimmer, H.G. and Neyses, L.
Abstract:	The plasma membrane calmodulin-dependent calcium ATPase (PMCA) is a calcium-extruding enzyme controlling Ca2+ homeostasis in nonexcitable cells. However, its function in the myocardium is unclear because of the presence of the Na+/Ca2+ exchanger. We approached the question of the physiological function of the calcium pump using a transgenic "gain of function" model. Transgenic rat lines carrying the human PMCA 4 cDNA under control of the ventricle-specific myosin light chain-2 promoter were established, and expression in the myocardium was ascertained at the mRNA, protein, and functional levels. In vivo hemodynamic measurements in adult homozygous animals showed no differences in baseline and increased cardiac performance recruited by volume overload compared with controls. No differences between transgenic and control cardiomyocytes were found in patch clamp voltage dependence, activation/inactivation behavior of the L-type Ca2+ current, or fast [Ca2+]i transients (assessed by the Fura-2 method). To test whether the PMCA might be involved in processes other than beat-to-beat regulation of contraction/relaxation, we compared growth processes of neonatal transgenic and control cardiomyocytes. A 1.6- and 2.3-fold higher synthesis rate of total protein was seen in cells from transgenic animals compared with controls on incubation with 2% FCS for 24 hours and 36 hours, respectively. An effect of similar magnitude was observed using 20 micromol/L phenylephrine. A 1.4-fold- and 2.0-fold-higher protein synthesis peak was seen in PMCA-overexpressing cardiomyocytes after stimulation with isoproterenol for 12 hours and 24 hours, respectively. Because pivotal parts of the alpha- and beta-adrenergic signal transduction pathways recently have been localized to caveolae, we tested the hypothesis that the PMCA might alter the amplitude of alpha- and beta-adrenergic growth signals by virtue of its localization in caveolae. Biochemical as well as immunocytochemical studies suggested that the PMCA in large part was colocalized with caveolin 3 in caveolae of cardiomyocytes. These results indicate that the sarcolemmal Ca2+-pump has little relevance for beat-to-beat regulation of contraction/relaxation in adult animals but likely plays a role in regulating myocardial growth, possibly through modulation of caveolar signal transduction.
Keywords:	Plasma Membrane Ca2+-ATPase, Myocardium, Transgenic Rat, Contraction, Cardiac Growth, Animals, Rats
Source:	Circulation Research
ISSN:	0009-7330
Publisher:	American Heart Association
Volume:	83
Number:	9
Page Range:	877-888
Date:	2 November 1998
Official Publication:	https://doi.org/10.1161/01.RES.83.9.877
PubMed:	View item in PubMed

Repository Staff Only: item control page